Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 3284 entries
View as:

Local Phase 4 Pan-European SMART Study

Phase: N/A Priority: Normal
NCT ID: NCT00463866 Org: User:
Start: 03/31/07 End: 12/31/08 Due: 12/31/09

Imjudo & Imfinzi PMS

Phase: N/A Priority: Normal
NCT ID: NCT06544629 Org: User:
Start: 04/14/25 End: 02/28/29 Due: 02/28/30

Tezepelumab PRO Study

Phase: N/A Priority: Normal
NCT ID: NCT05922891 Org: User:
Start: 09/27/23 End: 09/30/25 Due: 09/30/26

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04305496 Org: User:
Start: 04/16/20 End: 06/07/24 Due: 06/07/25

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT01042977 Org: User:
Start: 03/31/10 End: 12/31/12 Due: 12/31/13

REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06299306 Org: User:
Start: 05/07/24 End: 11/25/24 Due: 11/25/25

CARE FOR ALL：an Evaluation of an Asthma QIP

Phase: N/A Priority: Normal
NCT ID: NCT05440097 Org: User:
Start: 07/29/22 End: 09/03/24 Due: 09/03/25

Drug Interaction Study Between AZD3480 and Cytochrome P450

Phase: N/A Priority: Normal
NCT ID: NCT00692510 Org: User:
Start: 11/30/07 End: 09/30/08 Due: 09/30/09

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Phase: N/A Priority: Normal
NCT ID: NCT01171404 Org: User:
Start: 09/30/10 End: 03/31/13 Due: 03/31/14

Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01646424 Org: User:
Start: 08/31/12 End: 09/30/12 Due: 09/30/13

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02429258 Org: User:
Start: 05/31/15 End: 10/31/15 Due: 10/31/16

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Phase: N/A Priority: Normal
NCT ID: NCT00396240 Org: User:
Start: 02/28/02 End: - Due: -

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

Phase: N/A Priority: Normal
NCT ID: NCT01611272 Org: User:
Start: 04/30/13 End: 07/20/16 Due: 07/20/17

The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03216278 Org: User:
Start: 09/26/17 End: 05/22/18 Due: 05/22/19

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Phase: N/A Priority: Normal
NCT ID: NCT02104804 Org: User:
Start: 05/07/14 End: 02/26/16 Due: 02/26/17

Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population

Phase: N/A Priority: Normal
NCT ID: NCT02153411 Org: User:
Start: 06/30/14 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

Phase: N/A Priority: Normal
NCT ID: NCT00427635 Org: User:
Start: 10/31/06 End: 04/30/09 Due: 04/30/10

A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

Phase: N/A Priority: Normal
NCT ID: NCT01635985 Org: User:
Start: 08/31/12 End: 12/31/12 Due: 12/31/13

Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03463525 Org: User:
Start: 10/24/18 End: 10/05/20 Due: 10/05/21

Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00486265 Org: User:
Start: 07/31/07 End: 07/31/09 Due: 07/31/10

AZD7325 Japan Multiple Ascending Dose (MAD) Study

Phase: N/A Priority: Normal
NCT ID: NCT00945425 Org: User:
Start: 07/31/09 End: 11/30/09 Due: 11/30/10

AZD9496 First Time in Patients Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT02248090 Org: User:
Start: 10/22/14 End: 04/03/19 Due: 04/03/20

ARIA (Atacand Renoprotection In NephropAthy Pt.)

Phase: N/A Priority: Normal
NCT ID: NCT00573430 Org: User:
Start: 12/31/07 End: 08/31/09 Due: 08/31/10

C-Reactive Protein (CRP) in Obese Diabetic Women

Phase: N/A Priority: Normal
NCT ID: NCT00262548 Org: User:
Start: 10/31/05 End: - Due: -

Durvalumab and Tremelimumab for Pediatric Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03837899 Org: User:
Start: 03/07/19 End: 12/30/24 Due: 12/30/25